Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-08-03 Option Award |
2023-08-04 5:34 pm |
N/A 2033-08-02 |
Structure Therapeutics Inc. | GPCR | LOVE TED W Director |
75,000 | $0 | 75,000 (Direct) |
View |
2023-05-10 Other |
2023-05-12 8:00 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
7,410,518 | $0 | 19,994,977 (Direct) |
View |
Ownership |
2023-02-13 8:05 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
0 | $0 | 12,584,459 (Direct) |
View |
2023-02-07 Conversion |
2023-02-09 7:12 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | WELCH DANIEL G Director |
123,508 | $0 | 123,508 (Indirect) |
View |
2023-02-07 Conversion |
2023-02-09 7:09 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | Farid Ramy Director |
642,245 | $0 | 3,535,495 (Indirect) |
View |
2023-02-07 Conversion |
2023-02-09 2:42 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | FMR LLC See Remark 1 |
5,816,554 | $0 | 4,769,404 (Indirect) |
View |
2023-02-07 Conversion |
2023-02-09 2:04 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | FIL Ltd See Remark 1 |
6,473,761 | $0 | 624,239 (Indirect) |
View |
2023-02-02 Option Award |
2023-02-06 4:47 pm |
N/A 2033-02-01 |
Structure Therapeutics Inc. | GPCR | Yoon Jun Chief Financial Officer |
750,000 | $0 | 750,000 (Direct) |
View |
2023-02-02 Option Award |
2023-02-06 4:45 pm |
N/A 2033-02-01 |
Structure Therapeutics Inc. | GPCR | Stevens Raymond C Chief Executive Officer |
1,600,000 | $0 | 1,600,000 (Direct) |
View |
Ownership |
2023-02-02 6:34 pm |
N/A 2032-12-18 |
Structure Therapeutics Inc. | GPCR | Waldstreicher Joanne Director |
0 | $0 | 80,000 (Direct) |
View |
Ownership |
2023-02-02 6:30 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | FIL Ltd See Remark 1 10% Owner |
0 | $0 | 6,473,761 (Indirect) |
View |
Ownership |
2023-02-02 6:29 pm |
N/A 2032-12-18 |
Structure Therapeutics Inc. | GPCR | DOBMEIER ERIC Director |
0 | $0 | 80,000 (Direct) |
View |
Ownership |
2023-02-02 6:26 pm |
N/A 2032-05-11 |
Structure Therapeutics Inc. | GPCR | TETLOW SHARON Director |
0 | $0 | 80,000 (Direct) |
View |
Ownership |
2023-02-02 6:24 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | Farid Ramy Director |
0 | $0 | 3,260,495 (Indirect) |
View |
Ownership |
2023-02-02 6:23 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | WELCH DANIEL G Director |
0 | $0 | 1,302,630 (Indirect) |
View |
Ownership |
2023-02-02 6:21 pm |
N/A 2032-01-19 |
Structure Therapeutics Inc. | GPCR | Ma Yingli Chief Technology Officer |
0 | $0 | 400,000 (Direct) |
View |
Ownership |
2023-02-02 6:19 pm |
N/A 2031-09-22 |
Structure Therapeutics Inc. | GPCR | Jung Melita Sun Chief Business Officer |
0 | $0 | 465,290 (Direct) |
View |
Ownership |
2023-02-02 6:13 pm |
N/A 2031-09-22 |
Structure Therapeutics Inc. | GPCR | Bach Mark Allen Chief Medical Officer |
0 | $0 | 581,610 (Direct) |
View |
Ownership |
2023-02-02 6:12 pm |
N/A 2029-09-10 |
Structure Therapeutics Inc. | GPCR | Lin Xichen Chief Scientific Officer |
0 | $0 | 568,000 (Direct) |
View |
Ownership |
2023-02-02 6:11 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | FMR LLC See Remark 1 10% Owner |
0 | $0 | 5,816,554 (Indirect) |
View |
Ownership |
2023-02-02 6:09 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | Yoon Jun Chief Financial Officer |
0 | $0 | 2,818,250 (Direct) |
View |
Ownership |
2023-02-02 6:07 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | Stevens Raymond C Chief Executive Officer |
0 | $0 | 3,257,017 (Direct) |
View |